MORGES, Switzerland, Oct. 16, 2026 /PRNewswire/ -- Spectrum Dynamics Medical today announced the completion of initial clinical experience with the All-Energy Enhancement for the VERITON-CT 400 Series at four leading institutions. The work demonstrated high-energy theranostics imaging without compromising diagnostic performance. Following this milestone, the system enhancement, launched in July 2026, will now be known as the VERITON-CT 400...
Pope Leo has had breakfast after a good night in hospital, the Vatican says, two days after he had part of a lung removed due to cancer.
Free abortion care in Victoria has bipartisan support after the opposition matched Labor's election pledge just hours after it was announced.
An 83-year-old retired nurse is among millions of older Australians who face paying more for health insurance if controversial government plans pass parliament.
PARIS, Oct. 15, 2026 /PRNewswire/ -- A new real-world study from Opella, the maker of Mucosolvan and Bisolvon, provides pharmacists with compelling evidence that the success of a cough treatment should be measured by its impact on a patient's overall well-being, alongside traditional symptomatic relief.With most consumers1 making treatment decisions in the pharmacy, the pharmacist's recommendation plays a pivotal role in helping patients...
The illicit tobacco trade is still going strong through the use of fake Australian plain packaging, as crime groups operate factories across Southeast Asia.
An Australian-led study has called for international guidelines on endometriosis treatment after a global analysis found many countries have none.
A plan to cut health insurance rebates for older Australians has been blocked for now, due to a combined move in the upper house by the coalition and Greens.
MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that 20 company-related abstracts will be presented at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Vienna, Austria from October 17-21, 2026.Dr. David N. Cade, Telix Group Chief Medical Officer, said, "Our expansive presence at EANM reflects the...
More than half a billion of taxpayer dollars is needed to overhaul Australia's largest state public mental health service to help cure its funding headaches.
The High Court has opened the door to more women freezing their eggs behind bars after it overturned a state's decision banning a prisoner from the procedure.
Pope Leo has spent a peaceful night in hospital after undergoing surgery, with global leaders and the faithful offering prayers for the recovering pontiff.
SANTA BARBARA, Calif., Oct. 13, 2026 /PRNewswire/ -- Rona Therapeutics today announced it has granted Roche (SIX: RO, ROG; OTCQX: RHHBY) an exclusive worldwide license for Rona's investigational RNAi candidate targeting activin receptor-like kinase 7 (ALK7) utilizing the company's proprietary extrahepatic delivery platform.ALK7, encoded by the ACVR1C gene, is predominantly expressed in adipose tissue and is a genetically validated target for...
SHANGHAI, Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK0406, a long-acting antiviral drug-Fc conjugate (AFC), enabling the company to initiate a phase II clinical trial for influenza prevention in general population in the United States.Addressing Gaps in Influenza...
LUCERNE, Switzerland and NEW DELHI, Oct. 13, 2026 /PRNewswire/ -- The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against contemporary drug-eluting stents (DES) in patients with complex coronary artery disease.Designed to generate comparative evidence, SPARX aims to address key unanswered clinical...
More older Australians are arriving in emergency rooms, placing strain on hospitals and increasing the caseload beyond "bread and butter" work.
BEIJING, Oct. 12, 2026 /PRNewswire/ -- T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate a Phase 2 clinical study of MT027, its internally developed, B7-H3-targeted universal (allogeneic) CAR-T therapy, for the treatment of patients with brain metastases from lung cancer and breast cancer.This is the second Phase 2 study of MT027 to receive FDA clearance....
SHANGHAI and HONG KONG, Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that it will release the latest preclinical results of ATG-207...
BOSTON, Oct. 8, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: AZN). PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous recombination deficiency (HRD) in...
Russia's health regulator has rejected reports that a second person fell ill following the death of a worker at a plague research laboratory in Siberia.
LONDON, Oct. 7, 2026 /PRNewswire/ -- OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product's potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetration of tyrosine kinase inhibitors (TKIs).OB-001 is a highly selective and effective inhibitor of two key efflux pumps (P-gp and BCRP), which are...
Russian health officials state comprehensive tests have revealed no evidence of plague after a lab worker died in Siberia, as locals ditch their face masks.
The coalition maintains aged care workers will not be impacted by plans to slash migration, despite the sector's high reliance on temporary visa holders.
LONDON, ON and HERZLIYA, Israel, Oct. 5, 2026 /PRNewswire/ -- EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease interpretation.The collaboration combines EpiSign's expertise in DNA methylation episignature analysis with Geneyx's genomic and multi-omics capabilities. EpiSign METRIC is available to Geneyx customers, allowing laboratories to...
Russian authorities have quarantined part of a hospital and are monitoring contacts of a plague research institute worker in Siberia who died.
Disease-carrying mosquitoes thrive in warmer temperatures, raising concerns over the impacts of climate change and what it means for Australia's tropics.
MELBOURNE, Australia and BASEL, Switzerland, Oct. 5, 2026 /PRNewswire/ -- CSL and Alentis Therapeutics today announced they have entered into an exclusive global collaboration agreement to co-develop and co-promote lixudebart, which has the potential to become a first-in-class therapy targeting claudin-1 across a range of kidney, liver and other diseases.Lixudebart is currently being evaluated in the ongoing Phase 2 RENAL trial in patients...
MILAN, Oct. 4, 2026 /PRNewswire/ -- At the European Association for the Study of Diabetes (EASD) 2026, SiBionics presented "See More, Act Earlier," connecting continuous sensing with future diabetes care. Three exhibition chapters shaped this vision: "See More: Beyond Glucose," covering glucose, ketone and combined monitoring; "Act Earlier: From Insight to Intervention," exploring multimodal sensing and insulin delivery; and "Go Further:...
Families are still largely in the dark about what will happen when their kids are moved off the NDIS onto state supports as a transition period gets underway.
Advocates are calling for certainty on how NDIS supports will be impacted after the first phase of a program to take children with autism off the scheme begins.
BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational Live Double Combined Lactobacillus Capsule for Vaginal Use for the treatment of bacterial vaginosis (BV) were published in the National Medical Journal of China. The eight-center study randomized 66 patients in an approximately 2:1 ratio to the...
